Polymorphic variants in TSC1 and TSC2 and their association with breast cancer phenotypes

Breast Cancer Research and Treatment

Volumn 125, Issue 3, 2011, Pages 861-868

  Mehta, Madhura S ^a   Vazquez, Alexei ^a   Kulkarni, Diptee A ^a   Kerrigan, John E ^a   Atwal, Gurinder ^b   Metsugi, Shoichi ^c   Toppmeyer, Deborah L ^a   Levine, Arnold J ^a,c   Hirshfield, Kim M ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

^c INSTITUTE FOR ADVANCED STUDY   (United States)

Author keywords

Breast cancer risk; Case study; SNP; TSC1 TSC2

Indexed keywords

ESTROGEN RECEPTOR; GENOMIC DNA; ONCOPROTEIN; PROTEIN TSC1; TUBERIN; UNCLASSIFIED DRUG;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; ASIAN; BIOINFORMATICS; BREAST CANCER; BREAST CARCINOGENESIS; CAUCASIAN; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; BREAST NEOPLASMS; CARCINOMA, DUCTAL; COMPUTATIONAL BIOLOGY; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOTYPE; HAPLOTYPES; HUMANS; PHENOTYPE; POLYMORPHISM, GENETIC; TIME FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 79151470306     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-1062-1     Document Type: Article

References (28)

1. TJ Key PK Verkasalo E Banks 2001 Epidemiology of breast cancer Lancet Oncol 2 3 133 140 1:STN:280:DC%2BD387ntFelsw%3D%3D 10.1016/S1470-2045(00)00254-0 11902563 (Pubitemid 33585924)
2. IC Bennett M Gattas BT Teh 1999 The genetic basis of breast cancer and its clinical implications Aust N Z J Surg 69 2 95 105 1:STN:280: DyaK1M7ltlyrsg%3D%3D 10.1046/j.1440-1622.1999.01515.x 10030809 (Pubitemid 29082822)
3. C Turnbull N Rahman 2008 Genetic predisposition to breast cancer: past, present, and future Annu Rev Genomics Hum Genet 9 321 345 1:CAS:528: DC%2BD1cXht1SnsbbO 10.1146/annurev.genom.9.081307.164339 18544032
4. AM Dunning, et al. 1999 A systematic review of genetic polymorphisms and breast cancer risk Cancer Epidemiol Biomarkers Prev 8 10 843 854 1:CAS:528:DyaK1MXns1CrtLw%3D 10548311
5. GL Bond, et al. 2006 MDM2 SNP309 accelerates tumor formation in a gender-specific and hormone-dependent manner Cancer Res 66 10 5104 5110 1:CAS:528:DC%2BD28XksF2isr0%3D 10.1158/0008-5472.CAN-06-0180 16707433 (Pubitemid 43844932)
6. WS Rubinstein 2008 Hereditary breast cancer: pathobiology, clinical translation, and potential for targeted cancer therapeutics Fam Cancer 7 1 83 89 10.1007/s10689-007-9147-7 17624601
7. M Martin 2006 Molecular biology of breast cancer Clin Transl Oncol 8 1 7 14 1:CAS:528:DC%2BD28XhvF2rtb8%3D 10.1007/s12094-006-0089-6 16632434
8. J Huang BD Manning 2008 The TSC1-TSC2 complex: a molecular switchboard controlling cell growth Biochem J 412 2 179 190 1:CAS:528:DC%2BD1cXlvVWmsb8%3D 10.1042/BJ20080281 18466115 (Pubitemid 351758225)
9. PJ de Vries CJ Howe 2007 The tuberous sclerosis complex proteins-a GRIPP on cognition and neurodevelopment Trends Mol Med 13 8 319 326 10.1016/j.molmed.2007.06.003 17632034 (Pubitemid 47126986)
10. Orlova KA, Crino PB (2010) The tuberous sclerosis complex. Ann N Y Acad Sci 1184:87-105
11. JJ Yu, et al. 2009 Estrogen promotes the survival and pulmonary metastasis of tuberin-null cells Proc Natl Acad Sci USA 106 8 2635 2640 1:CAS:528:DC%2BD1MXislahsLo%3D 10.1073/pnas.0810790106 19202070
12. B York, et al. 2005 Cross-talk between tuberin, calmodulin, and estrogen signaling pathways FASEB J 19 9 1202 1204 1:CAS:528:DC%2BD2MXlvFens7Y%3D 15851513
13. JR Sampson 2009 Therapeutic targeting of mTOR in tuberous sclerosis Biochem Soc Trans 37 Pt 1 259 264 1:CAS:528:DC%2BD1MXotVWlug%3D%3D 10.1042/BST0370259 19143643
14. F Meric-Bernstam AM Gonzalez-Angulo 2009 Targeting the mTOR signaling network for cancer therapy J Clin Oncol 27 13 2278 2287 1:CAS:528: DC%2BD1MXlvFOgs7k%3D 10.1200/JCO.2008.20.0766 19332717
15. N Hay N Sonenberg 2004 Upstream and downstream of mTOR Genes Dev 18 16 1926 1945 1:CAS:528:DC%2BD2cXmvFKqsLk%3D 10.1101/gad.1212704 15314020 (Pubitemid 39071573)
16. DN Franz, et al. 2006 Rapamycin causes regression of astrocytomas in tuberous sclerosis complex Ann Neurol 59 3 490 498 1:CAS:528: DC%2BD28XjtV2ltr8%3D 10.1002/ana.20784 16453317 (Pubitemid 43358069)
17. WG Jiang, et al. 2005 Tuberin and hamartin are aberrantly expressed and linked to clinical outcome in human breast cancer: the role of promoter methylation of TSC genes Eur J Cancer 41 11 1628 1636 1:CAS:528: DC%2BD2MXmsVCmurk%3D 10.1016/j.ejca.2005.03.023 15951164 (Pubitemid 40981846)
18. TA Feo MGC Resende 1995 Greedy randomized adaptive search procedures J Glob Optim 6 2 109 133 10.1007/BF01096763
19. H Mizuno, et al. 2010 Fine-scale detection of population-specific linkage disequilibrium using haplotype entropy in the human genome BMC Genet 11 1 27 10.1186/1471-2156-11-27 20416085
20. Vazquez A et al (2010) Chemosensitivity profiles identify polymorphisms in the p53 network genes 14-3-3tau and CD44 that affect sarcoma incidence and survival. Cancer Res 70(1): 172-180
21. A Vazquez, et al. 2008 The genetics of the p53 pathway, apoptosis and cancer therapy Nat Rev Drug Discov 7 12 979 987 1:CAS:528:DC%2BD1cXhsVenu7rK 10.1038/nrd2656 19043449
22. Z Feng, et al. 2005 The coordinate regulation of the p53 and mTOR pathways in cells Proc Natl Acad Sci USA 102 23 8204 8209 1:CAS:528: DC%2BD2MXlsV2mt74%3D 10.1073/pnas.0502857102 15928081 (Pubitemid 40800067)
23. CM Klinge 2001 Estrogen receptor interaction with estrogen response elements Nucl Acids Res 29 14 2905 2919 1:CAS:528:DC%2BD3MXlslCktbY%3D 10.1093/nar/29.14.2905 11452016
24. Jerry DJ, Dunphy KA, Hagen MJ (2010) Estrogens, regulation of p53 and breast cancer risk: a balancing act. Cell Mol Life Sci 67(7): 1017-1023
25. S Sangrajrang, et al. 2009 Genetic polymorphisms of estrogen metabolizing enzyme and breast cancer risk in Thai women Int J Cancer 125 4 837 843 1:CAS:528:DC%2BD1MXnsFeltLw%3D 10.1002/ijc.24434 19415745
26. L Zhang, et al. 2009 Association of genetic polymorphisms of ER-alpha and the estradiol-synthesizing enzyme genes CYP17 and CYP19 with breast cancer risk in Chinese women Breast Cancer Res Treat 114 2 327 338 1:CAS:528: DC%2BD1MXhsFWnu7w%3D 10.1007/s10549-008-9998-0 18629629
27. VW Setiawan, et al. 2009 Two estrogen-related variants in CYP19A1 and endometrial cancer risk: a pooled analysis in the Epidemiology of Endometrial Cancer Consortium Cancer Epidemiol Biomarkers Prev 18 1 242 247 1:CAS:528:DC%2BD1MXhvFeqsg%3D%3D 10.1158/1055-9965.EPI-08-0689 19124504
28. P Bertheau, et al. 2008 TP53 status and response to chemotherapy in breast cancer Pathobiology 75 2 132 139 1:CAS:528:DC%2BD1cXmvFGksbs%3D 10.1159/000123851 18544968 (Pubitemid 351820731)